{"id":49623,"date":"2022-10-14T00:02:30","date_gmt":"2022-10-13T22:02:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/"},"modified":"2022-10-14T00:02:30","modified_gmt":"2022-10-13T22:02:30","slug":"zoetis-declares-fourth-quarter-2022-dividend","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/","title":{"rendered":"Zoetis Declares Fourth Quarter 2022 Dividend"},"content":{"rendered":"
\n

PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS<\/a> #Fortune500<\/a>–The Board of Directors of Zoetis Inc.<\/a> (NYSE:ZTS) has declared a dividend of $0.325 per share for the fourth quarter of 2022. The dividend will be paid on Thursday, December 1, 2022, to all holders of record of the Company\u2019s common stock as of the close of business on Tuesday, November 1, 2022.\n<\/p>\n

<\/a><\/p>\n

\nAbout Zoetis<\/b>\n<\/p>\n

\nAs the world\u2019s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers to veterinarians and pet owners. The company\u2019s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $7.8 billion in 2021 with approximately 12,100 employees. For more information, visit www.zoetis.com<\/a>.\n<\/p>\n

\nDISCLOSURE NOTICES<\/span><\/i>\n<\/p>\n

\nForward-Looking Statements<\/span>: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management’s underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, including in the sections thereof captioned \u201cForward-Looking Statements and Factors That May Affect Future Results\u201d and \u201cItem 1A. Risk Factors,\u201d in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. Such risks and uncertainties may be amplified by the COVID-19 pandemic and its potential impact on the global economy and our business. These filings and subsequent filings are available online at www.sec.gov<\/a>, www.zoetis.com<\/a>, or on request from Zoetis.<\/i>\n<\/p>\n

\nZTS-COR
\n
<\/i>ZTS-IR
\n
<\/i>ZTS-FIN<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/span>:
\n
Bill Price
\n
1-973-443-2742 (o)
\n
william.price@zoetis.com<\/a><\/p>\n

Kristen Seely
\n
1-973-443-2777 (o)
\n
kristen.seely@zoetis.com<\/a><\/p>\n

<\/span>Investor<\/span>:
\n
Steve Frank
\n
1-973-822-7141 (o)
\n
steve.frank@zoetis.com<\/a><\/p>\n

Nick Soonthornchai
\n
1-973-443-2792 (o)
\n
nick.soonthornchai@zoetis.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS #Fortune500–The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the fourth quarter of 2022. The dividend will be paid on Thursday, December 1, 2022, to all holders of record of the Company\u2019s common stock as of the close of business on Tuesday, November 1, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49623","6":"format-standard","7":"category-industry"},"yoast_head":"\nZoetis Declares Fourth Quarter 2022 Dividend - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zoetis Declares Fourth Quarter 2022 Dividend - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS #Fortune500–The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the fourth quarter of 2022. The dividend will be paid on Thursday, December 1, 2022, to all holders of record of the Company\u2019s common stock as of the close of business on Tuesday, November 1, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-13T22:02:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221013005994\/en\/356607\/21\/Zoetis_c.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Zoetis Declares Fourth Quarter 2022 Dividend\",\"datePublished\":\"2022-10-13T22:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/\"},\"wordCount\":438,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005994\\\/en\\\/356607\\\/21\\\/Zoetis_c.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/\",\"name\":\"Zoetis Declares Fourth Quarter 2022 Dividend - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005994\\\/en\\\/356607\\\/21\\\/Zoetis_c.jpg\",\"datePublished\":\"2022-10-13T22:02:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005994\\\/en\\\/356607\\\/21\\\/Zoetis_c.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005994\\\/en\\\/356607\\\/21\\\/Zoetis_c.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/zoetis-declares-fourth-quarter-2022-dividend\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zoetis Declares Fourth Quarter 2022 Dividend\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zoetis Declares Fourth Quarter 2022 Dividend - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/","og_locale":"en_US","og_type":"article","og_title":"Zoetis Declares Fourth Quarter 2022 Dividend - Pharma Trend","og_description":"PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS #Fortune500–The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the fourth quarter of 2022. The dividend will be paid on Thursday, December 1, 2022, to all holders of record of the Company\u2019s common stock as of the close of business on Tuesday, November 1, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-13T22:02:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221013005994\/en\/356607\/21\/Zoetis_c.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Zoetis Declares Fourth Quarter 2022 Dividend","datePublished":"2022-10-13T22:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/"},"wordCount":438,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221013005994\/en\/356607\/21\/Zoetis_c.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/","url":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/","name":"Zoetis Declares Fourth Quarter 2022 Dividend - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221013005994\/en\/356607\/21\/Zoetis_c.jpg","datePublished":"2022-10-13T22:02:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221013005994\/en\/356607\/21\/Zoetis_c.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221013005994\/en\/356607\/21\/Zoetis_c.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/zoetis-declares-fourth-quarter-2022-dividend\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Zoetis Declares Fourth Quarter 2022 Dividend"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49623"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49623\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}